Ex-Apple CEO John Sculley: People Want to See More Than Google and Facebook
Former Apple CEO John Sculley sees big shifts in the ad tech industry, as marketing becomes more personalized. And as smaller companies look to survive, he says they’re turning to Zeta Global, which he co-founded ten years ago.
“There’s so many companies that are for sale because they are too small to be able to compete in the mainstream,” he told Cheddar Monday. “We’ve been constantly approached by companies wanting us to acquire them.”
Just last week, the marketing cloud company bought Disqus, which powers the comment section of websites like TMZ and The Atlantic, services over 4 million websites, and hosts 2 billion monthly unique users.
Sculley also commented on the state of digital advertising, which has been largely dominated by Facebook and Google. He says customers want to broaden their advertising options.
“People want to see other alternatives in addition to Google and Facebook,” he said. “And it’s why you see companies like Zeta Global, and Adobe, and Salesforce.com, and others enjoying so much attention. You have to build out a broader platform.”
A report shows that a majority of young adults get their money advice on social media. Kendall Meade, financial planner at SoFi, joined Cheddar News to explain how to vet economic tips on social media.
Ryan Begin, Divert's CEO and co-founder, joined Cheddar News after the company recently received $1 billion infrastructure development agreement with Enbridge to support its efforts to protect the value of food.
John Peyton, CEO, of Dine Brands, parent company of IHOP and Applebee's, joined Cheddar News to discuss the company's latest earnings results and venture into fast casual with the acquisition of Fuzzy’s Taco Shop.
There were a record 2.6 million weddings in 2022, which is up from 1.9 million in 2021 and 1.3 million in 2020, according to a report from The Knot, a wedding planning agency.
In line with a Biden administration proposal, pharmaceutical giant Eli Lilly is cutting the price of its most commonly prescribed insulins by 70 percent and capping out-of-pocket costs at $35 or less per month.
